rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    DOCS
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      DOCS Expands Clinical AI Tools Across Three Major U.S. Health Systems
      Nov 16Yahoo FinanceDOCS
      Doximity expands AI tools to NewYork-Presbyterian hospitals
      Nov 13Investing.comDOCS
      Doximity to Provide New Clinical AI Tools Across NewYork-Presbyterian, Columbia University and Weill Cornell Medicine

      NEW YORK & SAN FRANCISCO, November 13, 2026--Doximity, the leading digital platform for U.S. medical professionals, NewYork-Presbyterian, Columbia University and Weill Cornell Medicine today announced that Doximity will provide clinical staff at all three academic healthcare institutions with additional AI-powered clinical decision support and scribe tools.

      Nov 13Yahoo FinanceDOCS
      More Than Half of U.S. Physicians Now Use AI In Their Practice Daily, But Few Have Clear Rules For It
      Nov 12Financial TimesDOCS
      Levi & Korsinsky Reminds Doximity, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 16, 2026 - DOCS
      Nov 11MorningstarDOCS
      DOCS Deadline: DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit
      Nov 10MorningstarDOCS
      Doximity (DOCS) Rolls Out DoseCheck After Near Zero Drug Dosing Errors

      Doximity (NYSE:DOCS) has launched DoseCheck, an AI-powered safety layer inside its Doximity Ask clinical decision support tool. The company reports DoseCheck cuts medication dosing errors by over 99% and has reached a near zero error rate in testing. DoseCheck verifies drug dosing recommendations against FDA labeling and professional guidelines and is available free to all Doximity Ask users. The launch of DoseCheck, with its near zero dosing error record, comes as broader research uncovers...

      Nov 10Yahoo FinanceDOCS
      What Should Doximity, Inc. Investors Know After 23% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class Action Lead Plaintiff Deadline
      Nov 10MorningstarDOCS
      Doximity: 3 Key Takeaways for Long-Term Investors
      Nov 10Yahoo FinanceDOCS
      Doximity Q2 Earnings Call Highlights
      Nov 7Yahoo FinanceDOCS
      Doximity earnings analysis: questions answered and next catalysts
      Nov 6Investing.comDOCS
      Why is Doximity stock sliding today?
      Nov 6Investing.comDOCS
      Doximity, Inc. Q2 2027 Earnings Call Summary
      Nov 6Yahoo FinanceDOCS
      Doximity (DOCS) Q2 2027 Earnings Call Transcript

      Motley Fool Press Release.

      Nov 6The Globe and MailDOCS
      Doximity Inc (DOCS) Q2 2027 Earnings Call Highlights: AI Search Becomes Eight-Figure Business ...
      Nov 6Yahoo FinanceDOCS
      Doximity Q2 2027 Earnings Call Transcript
      Nov 5BenzingaDOCS
      Doximity Stock Slips on Q2 Earnings: Key Details
      Nov 5BenzingaDOCS
      Compared to Estimates, Doximity (DOCS) Q2 Earnings: A Look at Key Metrics
      Nov 5Yahoo FinanceDOCS
      Doximity falls as margins decline despite earnings beat
      Nov 5Investing.comDOCS
      Doximity (DOCS) Beats Q2 Earnings and Revenue Estimates
      Nov 5Yahoo FinanceDOCS
      Doximity: Fiscal Q2 Earnings Snapshot
      Nov 5Yahoo FinanceDOCS
      Doximity’s (NYSE:DOCS) Q3 CY2026 sales beat estimates but stock drops

      Medical professional network Doximity (NYSE:DOCS) announced better-than-expected revenue in calendar Q3 2026 (fiscal Q2 2027), with revenue up 3.6% year on year to $174.5 million. The company expects next quarter’s revenue to be around $195.5 million, close to analysts’ consensus estimates. Its non-GAAP profit of $0.36 per share was in line with analysts’ consensus estimates.

      Nov 5Yahoo FinanceDOCS
      Doximity Announces Fiscal 2027 Second Quarter Financial Results
      Nov 5Yahoo FinanceDOCS
      DOCS Investor Alert: Doximity, Inc. Securities Class Action Notice - Contact SueWallSt
      Nov 5MorningstarDOCS
      Doximity director Wampler sells $65,780 in shares
      Nov 5Investing.comDOCS
      Earnings To Watch: Doximity Inc (DOCS) Q2 2027 -- GF Value Sees 53% Upside
      Nov 4Yahoo FinanceDOCS
      Curious about Doximity (DOCS) Q2 Performance? Explore Wall Street Estimates for Key Metrics
      Nov 3Yahoo FinanceDOCS
      Will DoseCheck Launch Change Doximity (DOCS) Narrative

      Doximity recently introduced DoseCheck, a free drug dosing safety layer inside its Ask tool that cross checks every AI generated recommendation against FDA labeling and professional guidelines, reporting more than 99% accuracy across over 8,000 real world dosing questions. The business is tightening clinical safety controls and, through the UpToDate content integration, embedding third party evidence directly into workflows for a user base that already includes over 85% of U.S. doctors and...

      Nov 2Yahoo FinanceDOCS
      Is Doximity (DOCS) Priced Right After Its DoseCheck Launch?
      Nov 2Yahoo FinanceDOCS
      Doximity (DOCS) Could Be 3% Undervalued Following DoseCheck And UpToDate Rollout
      Nov 2Yahoo FinanceDOCS
      What Is Doximity (DOCS) Really Building With Its New AI Dosing Tool?

      Doximity (NYSE:DOCS) has rolled out DoseCheck, an AI-driven medication dosing verification feature embedded in its Doximity Ask tool. DoseCheck adds a deterministic, rule-based layer that cross checks AI dosing suggestions to help reduce medication dosing errors for patients. The company is integrating UpToDate's evidence-based clinical content into its AI clinical support tool for point of care decision support. The combination of DoseCheck and UpToDate integration aligns with broader...

      Nov 2Yahoo FinanceDOCS
      Doximity (DOCS) Registers a Bigger Fall Than the Market: Important Facts to Note

      Doximity (DOCS) closed the most recent trading day at $33.63, moving 1.81% from the previous trading session.

      Oct 29Yahoo FinanceDOCS
      Doximity launches tool to verify AI drug dosing recommendations
      Oct 29Investing.comDOCS
      Doximity Launches DoseCheck to Catch Dangerous AI Drug Dosing Errors Before They Reach Doctors
      Oct 29Yahoo FinanceDOCS
      DOCS Shareholder Alert: Doximity, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky
      Oct 28MorningstarDOCS
      What Should Doximity, Inc. Investors Know After 23% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class Action Lead Plaintiff Deadline
      Oct 27MorningstarDOCS
      DOCS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Doximity, Inc. Securities Lawsuit - Contact SueWallSt
      Oct 22MorningstarDOCS
      Doximity (DOCS) Stock Gets Fair Value Bump As Analysts Split On AI And Margins
      Oct 22Yahoo FinanceDOCS
      Doximity: Demand For AI-Driven Platforms In Medical Sector Drives Longer-Term Buy (DOCS)
      Oct 21Seeking AlphaDOCS
      Stocks making big moves yesterday: Washington Trust Bancorp, Doximity, Myriad Genetics, Arhaus, and Gartner

      Detailed price information for Gartner Inc (IT-N) from The Globe and Mail including charting and trades.

      Oct 21The Globe and MailARHSDOCS
      Why Is Doximity (DOCS) Stock Rocketing Higher Today
      Oct 20Yahoo FinanceDOCS
      Doximity integrates UpToDate content into AI clinical tool
      Oct 20Investing.comDOCS
      Doximity and Wolters Kluwer Sign Partnership to Bring UpToDate to Doximity Ask – Company Announcement
      Oct 20Financial TimesDOCS
      DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit
      Oct 17MorningstarDOCS
      Doximity CAO Sitaram sells $80,166 of company stock
      Oct 17Investing.comDOCS
      Why Doximity (DOCS) Dipped More Than Broader Market Today

      Doximity (DOCS) closed the most recent trading day at $30.71, moving 2.51% from the previous trading session.

      Oct 16Yahoo FinanceDOCS
      Doximity stock sees Raymond James reiterate Outperform on settlement
      Oct 16Investing.comDOCS
      Kaplan Fox Announces a Securities Class Action Filed Against Doximity, Inc. (NYSE: DOCS) - Lead Plaintiff Deadline is November 16, 2026
      Oct 15BarchartDOCS
      Doximity Deepens U.S. News Alliance to Improve Patient Access to Care
      Oct 15Yahoo FinanceDOCS
      Doximity to Release Fiscal 2027 Second Quarter Results on November 5, 2026
      Oct 15Yahoo FinanceDOCS

      This is the newest page. Registered accounts read further back.